Evidence map›Paper›PMID 24847477›Full record

ArticleFrontiers in public health2014

Antidepressants: relationship to the time to psychiatric readmission and probability of being in hospital in depressive patients.

Ingeborg Warnke, Carlos Nordt, Jörn Moock, Wolfram Kawohl, Wulf Rössler

Abstract read
In one paragraph

Article in Frontiers in public health, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. FAM-FACE-SG: a score for risk stratification of frequent hospital admitters.BMC medical informatics and decision making · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ingeborg WarnkeCompetence Tandem, Innovation Incubator, Leuphana University Lüneburg , Lüneburg , Germany ; Department of Psychiatry, Psychotherapy and Psychosomatics, Center for Social Psychiatry, University Hospital of Psychiatry , Zurich , Switzerland.
Carlos NordtDepartment of Psychiatry, Psychotherapy and Psychosomatics, Center for Social Psychiatry, University Hospital of Psychiatry , Zurich , Switzerland.
Jörn MoockCompetence Tandem, Innovation Incubator, Leuphana University Lüneburg , Lüneburg , Germany.
Wolfram KawohlCompetence Tandem, Innovation Incubator, Leuphana University Lüneburg , Lüneburg , Germany ; Department of Psychiatry, Psychotherapy and Psychosomatics, Center for Social Psychiatry, University Hospital of Psychiatry , Zurich , Switzerland ; University of Zurich , Zurich , Switzerland.
Wulf RösslerCompetence Tandem, Innovation Incubator, Leuphana University Lüneburg , Lüneburg , Germany ; University of Zurich , Zurich , Switzerland ; Laboratory of Neuroscience, LIM27, Faculty of Medicine, University of Sao Paulo , Sao Paulo , Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAlthough antidepressants play a major role in the treatment of patients with depression, it is unclear which specific antidepressants are more efficacious than others. This study aims to analyze the relationship between several antidepressant substances and the time to readmission as well as the probability of being in hospital in a given week by using prescription data.

methodsThe database was health-insurance claim data from the new Federal States in Germany. The analysis consisted of all patients with unipolar depression at their index admission in 2007 (N = 1803). Patients were followed up for 2 years after discharge from index hospitalization. Statistical analyses were conducted by discrete-time hazards models and general estimation equation models, accounting for various predictors.

resultsOf all prescribed antidepressant substances, sertraline was related to an increased time to readmission by 37% and to a reduction in the probability of being in hospital in a given week by 40%. However, it was prescribed to only about 5% of the patients.

conclusionIn this study, only sertraline appeared to have clinical and economic advantages. It is remarkable that just a minority of patients received sertraline in our study, thus differing from the prescription pattern in the US.

Indexed as

antidepressantsdepressionprobability of being in hospitalsertralinetime hazard modelstime to psychiatric readmission

Identifiers

PMID24847477
PMCPMC4021117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.